Diversify With These Health ETFs
The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in…
Semaglutide Falls Short in Alzheimer’s Phase 3 Trials
Phase 3 trials show oral semaglutide failed to slow early Alzheimer’s progression, potentially limiting its expansion beyond metabolic…
A large-scale database for clinical trial outcomes and features
Global R&D expenditure for pharmaceuticals. Statista https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/#::̃text=In%202022%2C%20research%20and%20development,principal%20agency%20associated%20with%20processes (2025). Grand View Research Clinical trials market size, share & trends…
SuppCo launches certification to verify actives in dietary supplements
The new program complements SuppCo’s TrustScore supplement quality rating system and builds on earlier testing initiatives, which revealed…
AI breakthrough could dramatically lower the cost of drug development
Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The…
MIT scientists create pill capsule sensor to help doctors track missed doses
Missing a dose can feel small in the moment. But in transplant care, HIV, tuberculosis, and many heart…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
Baseline, Roche, Intellia, Eli Lilly: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
The new medicines and medical advances that defined 2025
It has been a tough year for medicine. The U.S. research enterprise has been scrambled by a series…
Pharma’s ‘Dr. Optimistic’ is worried about the industry’s future
In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview me about…
Mutual mistrust: FDA staff wary as Høeg becomes top drug regulator
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice…